Scientist.com’s first original service 'limits dead ends and unexpected surprises'

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Pinkeypills)
(Image: Getty/Pinkeypills)

Related tags: Data, Scientist.com

The online marketplace for outsourced research launches its first original service, which will provide researchers with on-demand insights into clinical trials – including trends in what is ‘hot’ and what is ‘not,’ says CBO.

The new service, Trial Insights, is a digital reporting solution, which collates data every night from publicly-available data sources such as ClinicalTrials.gov.

“The Trial Insights reporting dashboard is intended for those on the edge of evaluating an acquisition, looking for investigators to run their trial, wanting to keep tabs on competitors, as well as looking for trends in what is ‘hot’ and what is ‘not’ in drugs, targets, and biomarkers,” ​said Mark Herbert, chief business officer (CBO), Scientist.com.

“Trial Insights bridges the gap between integrated enterprise solutions, public databases, and mass export economy reports,”​ he told us.

Herbert said subscribers to the new service can scan for trends, avoid underperforming sites, identify new opportunities, access investigator heat maps, biomarker data, and more. This tailored data, delivered in real-time, can be shared to help users make better-informed decisions, he added.

“Trial Insights limits dead ends and unexpected surprises quickly and efficiently, so there are no wasted budgets,” ​Herbert said.

Related topics: Clinical Development, Data management

Related news

Show more

Related products

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Related suppliers

Follow us

Products

View more

Webinars